Analysts’ Recent Ratings Changes for Dolby Laboratories (DLB)

A number of firms have modified their ratings and price targets on shares of Dolby Laboratories (NYSE: DLB) recently:

• 1/31/2025 – Dolby Laboratories was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating.
• 1/30/2025 – Dolby Laboratories had its “buy” rating reaffirmed by analysts at Rosenblatt Securities. They now have a $100.00 price target on the stock.
• 1/27/2025 – Dolby Laboratories had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $100.00 price target on the stock.
• 1/23/2025 – Dolby Laboratories had its “buy” rating reaffirmed by analysts at Rosenblatt Securities. They now have a $100.00 price target on the stock.

Dolby Laboratories Price Performance

Shares of DLB traded down $0.23 during mid-day trading on Tuesday, reaching $83.92. 173,486 shares of the company’s stock were exchanged, compared to its average volume of 477,222. The business’s fifty day simple moving average is $79.42 and its 200-day simple moving average is $75.71. Dolby Laboratories, Inc. has a 52-week low of $66.35 and a 52-week high of $89.66. The stock has a market capitalization of $8.01 billion, a PE ratio of 30.85 and a beta of 0.98.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend is Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 48.53%.

Insider Transactions at Dolby Laboratories

In other news, SVP John D. Couling sold 7,000 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $80.50, for a total transaction of $563,500.00. Following the completion of the sale, the senior vice president now owns 106,806 shares in the company, valued at approximately $8,597,883. The trade was a 6.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Mark Andrew Sherman sold 40,000 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $84.88, for a total value of $3,395,200.00. Following the transaction, the executive vice president now directly owns 62,397 shares in the company, valued at $5,296,257.36. This trade represents a 39.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 175,917 shares of company stock valued at $14,272,939 in the last 90 days. 38.39% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors have recently made changes to their positions in DLB. Y Intercept Hong Kong Ltd acquired a new stake in shares of Dolby Laboratories in the fourth quarter valued at $246,000. Cardinal Capital Management increased its holdings in shares of Dolby Laboratories by 3.2% during the 4th quarter. Cardinal Capital Management now owns 41,453 shares of the electronics maker’s stock valued at $3,237,000 after acquiring an additional 1,273 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in shares of Dolby Laboratories by 8,415.6% during the 4th quarter. Venturi Wealth Management LLC now owns 3,832 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 3,787 shares during the last quarter. State of New Jersey Common Pension Fund D boosted its holdings in Dolby Laboratories by 6.1% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 29,603 shares of the electronics maker’s stock valued at $2,312,000 after purchasing an additional 1,693 shares during the period. Finally, Rhumbline Advisers grew its position in Dolby Laboratories by 0.5% in the 4th quarter. Rhumbline Advisers now owns 250,121 shares of the electronics maker’s stock worth $19,534,000 after purchasing an additional 1,194 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.